These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 22949939)

  • 21. [Change of Bcl-2 expression and telomerase during apoptosis induced by oridonin on human hepatocelluar carcinoma cells].
    Zhang JF; Chen GH; Lu MQ; Li H; Cai CJ; Yang Y
    Zhongguo Zhong Yao Za Zhi; 2006 Nov; 31(21):1811-4. PubMed ID: 17260801
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Oridonin induces apoptosis of HeLa cells via altering expression of Bcl-2/Bax and activating caspase-3/ICAD pathway.
    Zhang CL; Wu LJ; Tashiro S; Onodera S; Ikejima T
    Acta Pharmacol Sin; 2004 May; 25(5):691-8. PubMed ID: 15132839
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Apoptotic effect of oridonin on NB4 cells and its mechanism.
    Liu J; Huang R; Lin D; Wu X; Peng J; Lin Q; Pan X; Zhang M; Hou M; Chen F
    Leuk Lymphoma; 2005 Apr; 46(4):593-7. PubMed ID: 16019488
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Oridonin induces G2/M cell cycle arrest and apoptosis in human oral squamous cell carcinoma.
    Wang H; Zhu L; Feng X; Zhang H; Luo Q; Chen F
    Eur J Pharmacol; 2017 Nov; 815():282-289. PubMed ID: 28935563
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Oridonin induces apoptosis, inhibits migration and invasion on highly-metastatic human breast cancer cells.
    Wang S; Zhong Z; Wan J; Tan W; Wu G; Chen M; Wang Y
    Am J Chin Med; 2013; 41(1):177-96. PubMed ID: 23336515
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Oridonin induces G2/M cell cycle arrest and apoptosis through MAPK and p53 signaling pathways in HepG2 cells.
    Wang H; Ye Y; Chui JH; Zhu GY; Li YW; Fong DW; Yu ZL
    Oncol Rep; 2010 Sep; 24(3):647-51. PubMed ID: 20664969
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Oridonin induces growth inhibition and apoptosis in human gastric carcinoma cells by enhancement of p53 expression and function.
    Bi E; Liu D; Li Y; Mao X; Wang A; Wang J
    Braz J Med Biol Res; 2018 Nov; 51(12):e7599. PubMed ID: 30462771
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A novel combination of oridonin and valproic acid in enhancement of apoptosis induction of HL-60 leukemia cells.
    Shi M; Ren X; Wang X; Wang H; Liu G; Yuan X; Zheng S; Yu L; Pan S; Song G; Guo Q; Li L; Zhang X; Zhang Z; Ding H; Jiang G
    Int J Oncol; 2016 Feb; 48(2):734-46. PubMed ID: 26676928
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bcl-2 up-regulation and P-p53 down-regulation account for the low sensitivity of murine L929 fibrosarcoma cells to oridonin-induced apoptosis.
    Huang J; Wu L; Tashiro S; Onodera S; Ikejima T
    Biol Pharm Bull; 2005 Nov; 28(11):2068-74. PubMed ID: 16272691
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A new oridonin analog suppresses triple-negative breast cancer cells and tumor growth via the induction of death receptor 5.
    Wu J; Ding Y; Chen CH; Zhou Z; Ding C; Chen H; Zhou J; Chen C
    Cancer Lett; 2016 Oct; 380(2):393-402. PubMed ID: 27387452
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Effect of oridonin on apoptosis and intracellular reactive oxygen species level in triple-negative breast cancer MDA-MB-231 cells].
    Qi Q; Zhang P; Li QX; Pan Q; Zheng HL; Zhao SR
    Zhongguo Zhong Yao Za Zhi; 2017 Jun; 42(12):2361-2365. PubMed ID: 28822194
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of oridonin on proliferation of HT29 human colon carcinoma cell lines both in vitro and in vivo in mice.
    Zhu Y; Xie L; Chen G; Wang H; Zhang R
    Pharmazie; 2007 Jun; 62(6):439-44. PubMed ID: 17663191
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Oridonin effectively reverses cisplatin drug resistance in human ovarian cancer cells via induction of cell apoptosis and inhibition of matrix metalloproteinase expression.
    Ma S; Tan W; Du B; Liu W; Li W; Che D; Zhang G
    Mol Med Rep; 2016 Apr; 13(4):3342-8. PubMed ID: 26935490
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Anti-proliferative effects of oridonin on SPC-A-1 cells and its mechanism of action.
    Liu JJ; Huang RW; Lin DJ; Peng J; Wu XY; Pan XL; Li MQ; Lin Q
    J Int Med Res; 2004; 32(6):617-25. PubMed ID: 15587755
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Oridonin Induces Apoptosis in Human Nasopharyngeal Carcinoma Cells Involving ROS Generation.
    Zhang P; Zhao SR; Liu F; Sun XJ; Liu H
    Folia Biol (Praha); 2017; 63(4):155-163. PubMed ID: 29256858
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibition of caspase-9 by oridonin, a diterpenoid isolated from Rabdosia rubescens, augments apoptosis in human laryngeal cancer cells.
    Kang N; Cao SJ; Zhou Y; He H; Tashiro S; Onodera S; Qiu F; Ikejima T
    Int J Oncol; 2015 Dec; 47(6):2045-56. PubMed ID: 26648189
    [TBL] [Abstract][Full Text] [Related]  

  • 37. ROS/JNK/c-Jun axis is involved in oridonin-induced caspase-dependent apoptosis in human colorectal cancer cells.
    Zhang D; Zhou Q; Huang D; He L; Zhang H; Hu B; Peng H; Ren D
    Biochem Biophys Res Commun; 2019 Jun; 513(3):594-601. PubMed ID: 30981511
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inactivation of ras and changes of mitochondrial membrane potential contribute to oridonin-induced autophagy in a431 cells.
    Li D; Cui Q; Chen SG; Wu LJ; Tashiro S; Onodera S; Ikejima T
    J Pharmacol Sci; 2007 Sep; 105(1):22-33. PubMed ID: 17895587
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Oridonin exerts anticancer effect on osteosarcoma by activating PPAR-γ and inhibiting Nrf2 pathway.
    Lu Y; Sun Y; Zhu J; Yu L; Jiang X; Zhang J; Dong X; Ma B; Zhang Q
    Cell Death Dis; 2018 Jan; 9(1):15. PubMed ID: 29323103
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Oridonin, a diterpenoid purified from Rabdosia rubescens, inhibits the proliferation of cells from lymphoid malignancies in association with blockade of the NF-kappa B signal pathways.
    Ikezoe T; Yang Y; Bandobashi K; Saito T; Takemoto S; Machida H; Togitani K; Koeffler HP; Taguchi H
    Mol Cancer Ther; 2005 Apr; 4(4):578-86. PubMed ID: 15827331
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.